Infectious Disease Doctors in Wilkes Barre, PA Accepting Medicare

7 Infectious Disease doctors found. Showing 1 - 7

Jeff Hosry, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 675 Baltimore Dr, Wilkes Barre, PA 18702 Phone: 570-808-8889    Fax: 570-808-6367

Gary Raymond Decker, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 545 N River St, Suite 205, Wilkes Barre, PA 18702 Phone: 570-822-6036    Fax: 570-829-1520

Lucyann M Sciandra, DO Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 545 N River St, Suite 205, Wilkes Barre, PA 18702 Phone: 570-822-6036    Fax: 570-829-1520

Rowena Medina Jimenez, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 675 Baltimore Dr, Wilkes Barre, PA 18702 Phone: 570-808-8889    Fax: 570-808-6367

Linda A Slavoski, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 545 N River St, Suite 205, Wilkes Barre, PA 18702 Phone: 570-822-6036    Fax: 570-829-1520

Dr. Alison M Brodginski, D.O. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 675 Baltimore Dr., Wilkes Barre, PA 18702 Phone: 570-808-8889    Fax: 570-808-6367

Monica Ahuja, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-8889    Fax: 570-808-4050

News Archive

Lean beef can contribute to heart-healthy diet

Lean beef can contribute to a heart-healthy diet in the same way lean white meats can, according to nutritional scientists.

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.

Polyglot Systems, CCNC offer Meducation technology to North Carolina residents

Polyglot Systems, Inc. recently partnered with Community Care of North Carolina (CCNC), a Raleigh based health network operated by physicians, hospitals, health departments, and departments of social services, to offer Meducation® technology to support North Carolina residents who are considered low-health literate.

Viragen announces European Multiferon licensing agreement

Viragen and its majority-owned subsidiary, Viragen International have announced that a licensing agreement has been completed with Swedish Orphan International AB, granting exclusive marketing rights to Multiferon (multi-subtype, human alpha interferon) for the European Union (excluding previously licensed member states).

Read more Medical News

› Verified 8 days ago